Basic science and translational research
Invited discussant abstracts 1O and 1520O
Date
08 Oct 2016Session
Basic science and translational researchPresenters
Joan SeoaneAuthors
J. SeoaneAuthor affiliations
- Translational Research Program, Vall d`Hebron Institute of Oncology (VHIO)-Cellex Center, 08035 - Barcelona/ES
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
2657 - Availability of tumour gene expression data facilitates clinical decision-making for patients with advanced cancers
Presenter: Janessa Laskin
Session: Basic science and translational research
Resources:
Abstract
Slides
Webcast
3720 - Assessment and comparison of tumor mutational burden and microsatellite instability status in >40,000 cancer genomes
Presenter: David Fabrizio
Session: Basic science and translational research
Resources:
Abstract
Slides
Webcast
Invited discussant abstracts 1519O and 52O
Presenter: Sheila Singh
Session: Basic science and translational research
Resources:
Slides
Webcast
2219 - EPHA2 blockade overcomes primary and acquired resistance to anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer (mCRC)
Presenter: Giulia Martini
Session: Basic science and translational research
Resources:
Abstract
3003 - Lurbinectedin (PM01183) exhibits antitumor activity in PARP-inhibitor resistant germline BRCA PDX and lacks cross-resistance with cisplatin
Presenter: Cristina Cruz
Session: Basic science and translational research
Resources:
Abstract
2380 - Exploratory biomarkers in MONARCH 1, a phase II study of abemaciclib monotherapy in hormone-receptor positive (HR ) HER2- metastatic breast cancer (MBC)
Presenter: Sara Tolaney
Session: Basic science and translational research
Resources:
Abstract
1552 - Copy number alterations as predictive biomarkers for response to bevacizumab in metastatic colorectal cancer
Presenter: Nicole van Grieken
Session: Basic science and translational research
Resources:
Abstract
3480 - Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in cancer patients
Presenter: Christian Rolfo
Session: Basic science and translational research
Resources:
Abstract
3495 - Vemurafenib (VM) in non-melanoma V600 and non-V600 BRAF mutated cancers: first results of the ACSE trial
Presenter: Jean-Yves Blay
Session: Basic science and translational research
Resources:
Abstract
1570 - Extended genotyping of RAS/BRAF for improved selection of metastatic CRC patients to anti-EGFR therapy: Comparison of three platforms
Presenter: Daniel Azuara
Session: Basic science and translational research
Resources:
Abstract
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.